These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3012111)

  • 1. Recent clinical isolates of cytomegalovirus suppress human cytomegalovirus-specific human leukocyte antigen-restricted cytotoxic T-lymphocyte activity.
    Schrier RD; Oldstone MB
    J Virol; 1986 Jul; 59(1):127-31. PubMed ID: 3012111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
    Wills MR; Carmichael AJ; Mynard K; Jin X; Weekes MP; Plachter B; Sissons JG
    J Virol; 1996 Nov; 70(11):7569-79. PubMed ID: 8892876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytomegalovirus and monocytes: limited infection and negligible immunosuppression in normal mononuclear cells infected in vitro with mycoplasma-free virus strains.
    Scott DM; Rodgers BC; Freeke C; Buiter J; Sissons JG
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():685-94. PubMed ID: 2543753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
    Tabi Z; Moutaftsi M; Borysiewicz LK
    J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells.
    Boppana SB; Britt WJ
    Virology; 1996 Aug; 222(1):293-6. PubMed ID: 8806513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus.
    Schrier RD; Rice GP; Oldstone MB
    J Infect Dis; 1986 Jun; 153(6):1084-91. PubMed ID: 2422296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and expansion of human cytomegalovirus- specific cytotoxic T lymphocytes using interferon-gamma secretion assay.
    Bissinger AL; Rauser G; Hebart H; Frank F; Jahn G; Einsele H
    Exp Hematol; 2002 Oct; 30(10):1178-84. PubMed ID: 12384149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of cytotoxic T lymphocytes specific for human cytomegalovirus using dendritic cells in vitro.
    Cho HI; Han H; Kim CC; Kim TG
    J Immunother; 2001; 24(3):242-9. PubMed ID: 11394502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells.
    Lindsley MD; Torpey DJ; Rinaldo CR
    J Immunol; 1986 Apr; 136(8):3045-51. PubMed ID: 2420881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus-specific cytotoxic T lymphocytes: requirements for in vitro generation and specificity.
    Borysiewicz LK; Morris S; Page JD; Sissons JG
    Eur J Immunol; 1983 Oct; 13(10):804-9. PubMed ID: 6196203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus.
    Frankenberg N; Pepperl-Klindworth S; Meyer RG; Plachter B
    Virology; 2002 Apr; 295(2):208-16. PubMed ID: 12033779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T cell immunity to human cytomegalovirus glycoprotein B.
    Hopkins JI; Fiander AN; Evans AS; Delchambre M; Gheysen D; Borysiewicz LK
    J Med Virol; 1996 Jun; 49(2):124-31. PubMed ID: 8991935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice.
    Lenfant F; Pizzato N; Liang S; Davrinche C; Le Bouteiller P; Horuzsko A
    J Gen Virol; 2003 Feb; 84(Pt 2):307-317. PubMed ID: 12560562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.
    Liu Y; Freed DC; Li L; Tang A; Li F; Murray EM; Adler SP; McVoy MA; Rupp RE; Barrett D; Ye X; Zhang N; Beck K; Culp T; Das R; Song L; Vora K; Zhu H; Wang D; Espeseth AS; An Z; Musey L; Fu TM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses.
    Borysiewicz LK; Hickling JK; Graham S; Sinclair J; Cranage MP; Smith GL; Sissons JG
    J Exp Med; 1988 Sep; 168(3):919-31. PubMed ID: 2844952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques.
    Kaur A; Daniel MD; Hempel D; Lee-Parritz D; Hirsch MS; Johnson RP
    J Virol; 1996 Nov; 70(11):7725-33. PubMed ID: 8892893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of serum and CTL on focal growth of human cytomegalovirus.
    Sinzger C; Mangin M; Weinstock C; Topp MS; Hebart H; Einsele H; Jahn G
    J Clin Virol; 2007 Feb; 38(2):112-9. PubMed ID: 17204454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4
    Frascaroli G; Lecher C; Varani S; Setz C; van der Merwe J; Brune W; Mertens T
    Front Immunol; 2018; 9():1129. PubMed ID: 29887865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes.
    Gehrz RC; Rutzick SR
    Clin Exp Immunol; 1985 Jul; 61(1):80-9. PubMed ID: 2994924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminobisphosphonates Synergize with Human Cytomegalovirus To Activate the Antiviral Activity of Vγ9Vδ2 Cells.
    Daguzan C; Moulin M; Kulyk-Barbier H; Davrinche C; Peyrottes S; Champagne E
    J Immunol; 2016 Mar; 196(5):2219-29. PubMed ID: 26819204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.